Highlander Health, a firm advancing evidence generation and personalized health care for the new era of medical innovation, announces the acquisition of Target RWE from existing investors, including 22C Capital. Target RWE is a longitudinal data company that generates high-quality real-world datasets and evidence across multiple therapeutic areas, with liver disease as a flagship. Industry veterans Amy Abernethy, M.D., Ph.D., and Brad Hirsch, M.D. launched Highlander Health Partners in September of 2024 to invest in companies and technology crucial to personalized care for all, and Target RWE marks their first acquisition.
Read the full article: Highlander Health Announces Inaugural Investment of Target RWE //
Source: https://www.businesswire.com/news/home/20250107634634/en/Highlander-Health-Announces-Inaugural-Investment-of-Target-RWE